Galyna Mykhalchyshyn

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial

Nazarii Kobyliak, Ludovico Abenavoli, Galyna Mykhalchyshyn et al. · Journal of Gastrointestinal and Liver Diseases · 2018 · 254 citations · Full text

Effect of alive probiotic on insulin resistance in type 2 diabetes patients: Randomized clinical trial

Nazarii Kobyliak, Tetyana Falalyeyeva, Galyna Mykhalchyshyn et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 2018 · 196 citations

Insulin Resistance, Metabolic Syndrome, Nutrition +10

Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study

Nazarii Kobyliak, Ludovico Abenavoli, Tetyana Falalyeyeva et al. · Minerva Medica · 2018 · 105 citations

Probiotic and omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance, improves glycemia and obesity parameters in individuals with type 2 diabetes: A randomised controlled trial

Nazarii Kobyliak, Tetyana Falalyeyeva, Galyna Mykhalchyshyn et al. · Obesity Medicine · 2020 · 52 citations

Obesity, Nutrition, Metabolic Syndrome +11